Rep. Jan Schakowsky visits Wockhardt plant, commends production expansion in Illinois

Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing. Following a presentation of the facility's history, Representative Schakowsky toured the plant and inaugurated the Oral Solid facility that was created with $14 million capital investment. The facility is dedicated to the production of affordable, generic oral solid dose products.

In addition to the new Oral Solid Dose facility at Morton Grove, Wockhardt has recently added a new laboratory for Research & Development and additional laboratory space for Quality Control. With the recent acquisition of 9 acres of land adjacent to its existing facility, Wockhardt is poised to continue its rapid expansion in Morton Grove and increase the number of new jobs to the Morton Grove facility.

Wockhardt acquired Morton Grove Pharmaceuticals (MGP) in 2007.

SOURCE Wockhardt

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer